The same hazards remain:
Reports of thrombosis with thrombocytopenia syndrome following vaccination with AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine
Remains at 89
Reports of Guillain-Barré Syndrome (GBS) in Canada following AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccination. Data in Canada indicate a higher number of cases than would normally be expected in the general population
109 cases this week. Up 3 from last weeks high
Reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining around the heart) following vaccination with COVID-19 mRNA vaccines. Data in Canada now indicate a higher number of cases in younger people (i.e. less than 40 years of age) than would normally be expected in this age group in the general population.
1463 cases on lagging data, but, still up 35 cases.
Capillary leak syndrome following vaccination with the AstraZeneca Vaxzevria/COVISHIELD COVID-19 vaccine.
Count remains at 2
Facial paralysis/Bell’s Palsy following COVID-19 vaccination. Health Canada has updated the the Moderna Spikevax COVID-19 vaccine product monograph (PDF) and the Pfizer-BioNTech Comirnaty COVID-19 vaccine product monograph (PDF) to include information on facial paralysis/Bell’s Palsy.
689 cases of facial paralysis- up 10 from last week
Immune thrombocytopenia (ITP) and venous thromboembolism (VTE) following vaccination with the Janssen COVID-19 vaccine.
Thrombocytopenia including ITP following vaccination with AstraZeneca Vaxzevria COVID-19 vaccine.
253 on lagging data, up 5 from last weeks high of 248
Breakthrough infections a laughable 168- that number always informs on how truly out of touch with reality this entire report really is
Last time I’d tracked some of the weekly increases in data
Sept 3/21’s adverse reaction count is 895. It sat at 853 adverse reactions (two weeks ago)
August 27/21’s adverse reaction count has increase a great deal as well. Two weeks ago it was 659. Now it is 700.
The data lag is months- not weeks as this report would have you believe. Months worth of data lag.
11 serious adverse affects per 100,000 doses- I remember when we were told serious adverse affects were going to be one in a million. Now it looks like 110 per million. Should we consider this low?
Considering the US count is over 20,000 we know Canada’s can’t be just over 250.
Is Omicron being hyped to give cover to the myriad of economic issues that are upon us and likely to get worse?
And take note: The US is going to hand out Rapid Antigen Tests en masse- Admitting vaccine failure without uttering the truth.
500 million tests to American homes